Coherus BioSciences: Q1 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $75.7 million in its first quarter.

The Redwood City, California-based company said it had a loss of 96 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 75 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

The drug developer posted revenue of $32.4 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $50.7 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CHRS at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up